Francesco G. Salituro

ORCID：0000-0003-1172-7064

发表论文 104 篇 · 总被引 5448 次 · h-index 34

代表论文

• AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations (2017 · Cancer Discovery · 被引 473)
• Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers (2018 · ACS Medicinal Chemistry Letters · 被引 455)
• Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2 (2014 · Journal of Medicinal Chemistry · 被引 219)
• AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency (2017 · Blood · 被引 133)
• Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator (2020 · Neuropharmacology · 被引 132)
• Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor (2017 · Journal of Medicinal Chemistry · 被引 123)